Impact Investment: Interview with Arbele

  The Asian Fund for Cancer Research aims to accelerate cancer research and technologies through international collaborations.  As part of our mission, AFCR has created the BRACE Award Venture Competition to provide vital support to…

Read more

Promising Cancer Research Programs Need Your Help!

I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue…

Read more

AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!

Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent…

Read more

AFCR Congratulates Professor Nancy Ip for Being Appointed as the President of The Hong Kong University of Science and Technology (HKUST)

The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of…

Read more

Announcement: Chimera Bioengineering is the 2021 BRACE Award Venture Competition Winner

CONTACTS:Asian Fund for Cancer ResearchBradley Gillenwater, Senior Director for Corporate EngagementE-mail: bgillenwater@afcr.org Chimera BioengineeringVlad Hogenhuis, M.D., CEOE-mail: info@chimera.bio Little Dog CommunicationsJessica Yingling, Ph.D., PresidentE-mail: jessica@litldog.com / Phone: 1-858-344-8091 Asian Fund for Cancer Research Announces Chimera…

Read more